Remsima
Brand Name: Remsima
Generic Name: Infliximab
Active
Registration Number
BR-907
Dosage Form
Lyophilized Powder for Concentrate for Solution for Infusion (IV)
Issuance Date
August 2, 2023
Expiry Date
May 14, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100mg
Packaging20 mL Type I glass vial (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
A
Application
Renewal (Correction)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
InfliximabActive
Monograph: Infliximab